Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: biao luo who wrote (3174)	12/6/1997 9:52:00 PM
From: JOHN W.	Read Replies (2) of 6136

Freaking wrong and another bullshoot lie by those that will prosper trying to kill this company. Think about what you are saying, This big pharmaceutical company (Lilly) has a drug that they have develop and it is in their library, and then sought out this little biotechb to develop the product through clinical trial while paying them money to do so, and then sharing the profits for it's sales????? Why, because Lilliy was too busy? What did Lilly need AGPH for?? So then Lilly abandons their own drug and allows AGPH to develop it. So what happened, AGPH pay liliiy off for their drug? In a recent tech letter, I read that Glaxo was not impressed with the 70% response to VX-478 nad was planning to withdraw from the collaboration. And since you are a VRTX shareholder, do you also believe protease inhibitors will be obsolete in 5 yrs?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next